{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:17:34Z","timestamp":1775715454266,"version":"3.50.1"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1186\/s12920-019-0492-9","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T12:07:28Z","timestamp":1552565248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prioritization of genes involved in endothelial cell apoptosis by their implication in lymphedema using an analysis of associative gene networks with ANDSystem"],"prefix":"10.1186","volume":"12","author":[{"given":"Olga V.","family":"Saik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim V.","family":"Nimaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilovarkhuja B.","family":"Usmonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel S.","family":"Demenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timofey V.","family":"Ivanisenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna N.","family":"Lavrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir A.","family":"Ivanisenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"12","key":"492_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2217\/14622416.8.2.151","volume":"8","author":"N Farinola","year":"2007","unstructured":"Farinola N, Piller NB. CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients? Pharmacogenomics. 2007;8(12):151\u20138.","journal-title":"Pharmacogenomics"},{"issue":"9","key":"492_CR2","first-page":"3","volume":"9","author":"AF Poveshchenko","year":"2010","unstructured":"Poveshchenko AF, Nimaev VV, Lubarsky MS, Konenkov VI. Medical and genetical aspects of lymphedema. Med Genet. 2010;9(9):3\u20139.","journal-title":"Med Genet"},{"issue":"2","key":"492_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1358836X9800300209","volume":"3","author":"A Szuba","year":"1998","unstructured":"Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998;3(2):145\u201356.","journal-title":"Vasc Med"},{"issue":"6","key":"492_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000354097","volume":"4","author":"A Mendola","year":"2013","unstructured":"Mendola A, Schl\u00f6gel MJ, Ghalamkarpour A, Irrthum A, Nguyen HL, Fastr\u00e9 E, et al. Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema. Mol Syndromol. 2013;4(6):257\u201366.","journal-title":"Mol Syndromol"},{"issue":"3","key":"492_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1172\/JCI71614","volume":"124","author":"P Brouillard","year":"2014","unstructured":"Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest. 2014;124(3):898\u2013904.","journal-title":"J Clin Invest"},{"issue":"5","key":"492_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaoncol.2017.5553","volume":"4","author":"A Gupta","year":"2018","unstructured":"Gupta A, Moore JA. Lymphedema. JAMA Oncol. 2018;4(5):755.","journal-title":"JAMA Oncol"},{"issue":"1","key":"492_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/lrb.2013.0024","volume":"12","author":"G Leung","year":"2014","unstructured":"Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, et al. Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol. 2014;12(1):10\u201322.","journal-title":"Lymphat Res Biol"},{"issue":"4","key":"492_CR8","doi-asserted-by":"publisher","first-page":"e60164","DOI":"10.1371\/journal.pone.0060164","volume":"8","author":"C Miaskowski","year":"2013","unstructured":"Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, et al. Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS One. 2013;8(4):e60164.","journal-title":"PLoS One"},{"issue":"1","key":"492_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21253","volume":"65","author":"SF Shaitelman","year":"2015","unstructured":"Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, et al. Recent progress in cancer-related lymphedema treatment and prevention. CA Cancer J Clin. 2015;65(1):55.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"492_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/153968503768330265","volume":"1","author":"WL Olszewski","year":"2003","unstructured":"Olszewski WL. Pathophysiological aspects of lymphedema of human limbs: I. Lymph protein composition. Lymphat Res Biol. 2003;1(3):235\u201343.","journal-title":"Lymphat Res Biol"},{"issue":"389","key":"492_CR11","doi-asserted-by":"publisher","first-page":"eaal3920","DOI":"10.1126\/scitranslmed.aal3920","volume":"9","author":"W Tian","year":"2017","unstructured":"Tian W, Rockson SG, Jiang X, Kim J, Begaye A, Shuffle EM, Tu AB, Cribb M, Nepiyushchikh Z, Feroze AH, Zamanian RT. Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci Transl Med. 2017;9(389):eaal3920.","journal-title":"Sci Transl Med"},{"key":"492_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"J Kerr","year":"1972","unstructured":"Kerr J, Wyllie A, Currie A. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239\u201357.","journal-title":"Br J Cancer"},{"issue":"26","key":"492_CR13","doi-asserted-by":"publisher","first-page":"27088","DOI":"10.1074\/jbc.M314015200","volume":"279","author":"JF Wang","year":"2004","unstructured":"Wang JF, Zhang X, Groopman JE. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress. J Biol Chem. 2004;279(26):27088\u201397.","journal-title":"J Biol Chem"},{"issue":"1","key":"492_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/lrb.2010.0019","volume":"9","author":"S Ogunbiyi","year":"2011","unstructured":"Ogunbiyi S, Chinien G, Field D, Humphries J, Burand K, Sawyer B, et al. Smith, for the London lymphedema consortium a. Molecular characterization of dermal lymphatic endothelial cells from primary lymphedema skin. Lymphat Res Biol. 2011;9(1):19\u201330.","journal-title":"Lymphat Res Biol"},{"issue":"suppl_2","key":"492_CR15","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","volume":"37","author":"J Chen","year":"2009","unstructured":"Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37(suppl_2):W305\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"492_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrg3253","volume":"13","author":"Y Moreau","year":"2012","unstructured":"Moreau Y, Tranchevent LC. Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat Rev Genet. 2012;13(8):523.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"492_CR17","doi-asserted-by":"publisher","first-page":"e43557","DOI":"10.1371\/journal.pone.0043557","volume":"7","author":"E Guney","year":"2012","unstructured":"Guney E, Oliva B. Exploiting protein-protein interaction networks for genome-wide disease-gene prioritization. PLoS One. 2012;7(9):e43557.","journal-title":"PLoS One"},{"issue":"W1","key":"492_CR18","doi-asserted-by":"publisher","first-page":"W117","DOI":"10.1093\/nar\/gkw365","volume":"44","author":"LC Tranchevent","year":"2016","unstructured":"Tranchevent LC, Ardeshirdavani A, ElShal S, Alcaide D, Aerts J, Auboeuf D, et al. Candidate gene prioritization with Endeavour. Nucleic Acids Res. 2016;44(W1):W117\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"492_CR19","first-page":"15","volume":"11","author":"OV Saik","year":"2018","unstructured":"Saik OV, Demenkov PS, Ivanisenko TV, Bragina EY, Freidin MB, Goncharova IA, et al. Novel candidate genes important for asthma and hypertension comorbidity revealed from associative gene networks. BMC Med Genet. 2018;11(1):15.","journal-title":"BMC Med Genet"},{"issue":"1","key":"492_CR20","first-page":"153","volume":"22","author":"MA Yankina","year":"2018","unstructured":"Yankina MA, Saik OV, Demenkov PS, Khusnutdinova EK, Rogaev EI, Lavrik IN, et al. Analysis of the interactions of neuronal apoptosis genes in the associative gene network of Parkinson's disease. Vavilovskii Zhurnal Genetiki I SelektsII. 2018;22(1):153\u201360.","journal-title":"Vavilovskii Zhurnal Genetiki I SelektsII"},{"issue":"3, 4","key":"492_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/ISB-2012-0449","volume":"11","author":"PS Demenkov","year":"2012","unstructured":"Demenkov PS, Ivanisenko TV, Kolchanov NA, Ivanisenko VA. ANDVisio: a new tool for graphic visualization and analysis of literature mined associative gene networks in the ANDSystem. In Silico Biol. 2012;11(3, 4):149\u201361.","journal-title":"In Silico Biol"},{"issue":"2","key":"492_CR22","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1752-0509-9-S2-S2","volume":"9","author":"VA Ivanisenko","year":"2015","unstructured":"Ivanisenko VA, Saik OV, Ivanisenko NV, Tiys ES, Ivanisenko TV, Demenkov PS, et al. ANDSystem: an associative network discovery system for automated literature mining in the field of biology. BMC Syst Biol. 2015;9(2):S2.","journal-title":"BMC Syst Biol"},{"issue":"2","key":"492_CR23","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1752-0509-9-S2-S4","volume":"9","author":"AS Glotov","year":"2015","unstructured":"Glotov AS, Tiys ES, Vashukova ES, Pakin VS, Demenkov PS, Saik OV, et al. Molecular association of pathogenetic contributors to pre-eclampsia (pre-eclampsia associome). BMC Syst Biol. 2015;9(2):S4.","journal-title":"BMC Syst Biol"},{"issue":"7\u20138","key":"492_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00251-014-0786-1","volume":"66","author":"EY Bragina","year":"2014","unstructured":"Bragina EY, Tiys ES, Freidin MB, Koneva LA, Demenkov PS, Ivanisenko VA, et al. Insights into pathophysiology of dystropy through the analysis of gene networks: an example of bronchial asthma and tuberculosis. Immunogenetics. 2014;66(7\u20138):457\u201365.","journal-title":"Immunogenetics"},{"issue":"9","key":"492_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/jez.a.307","volume":"305","author":"CJ Mattingly","year":"2006","unstructured":"Mattingly CJ, Rosenstein MC, Colby GT, Forrest JN Jr, Boyer JL. The comparative Toxicogenomics database (CTD): a resource for comparative toxicological studies. J Exp Zool A Comp Exp Biol. 2006;305(9):689\u201392.","journal-title":"J Exp Zool A Comp Exp Biol"},{"issue":"D1","key":"492_CR26","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2016","unstructured":"Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, et al. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2016;45(D1):D877\u201387.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"492_CR27","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2016;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"492_CR28","doi-asserted-by":"publisher","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","volume":"45","author":"S K\u00f6hler","year":"2016","unstructured":"K\u00f6hler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Aym\u00e9 S, et al. The human phenotype ontology in 2017. Nucleic Acids Res. 2016;45(D1):D865\u201376.","journal-title":"Nucleic Acids Res"},{"key":"492_CR29","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero J, Bravo \u00c0, Queralt-Rosinach N, Guti\u00e9rrez-Sacrist\u00e1n A, Deu-Pons J, Centeno E, Garc\u00eda-Garc\u00eda J, Sanz F, Furlong LI. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2016;45(D1):D833-D839.","DOI":"10.1093\/nar\/gkw943"},{"key":"492_CR30","doi-asserted-by":"crossref","unstructured":"Usmonov DB, Saik OV, Nimaev VV. The possibilities of bioinformatic analysis in the study of the pathogenesis of lymphatic dysplasia: Engineering, Computer and Information Sciences (SIBIRCON). 2017 International multi-conference on 2017 Sep 18. Hoboken: Wiley-IEEE Press; 2017. p. 512\u20134.","DOI":"10.1109\/SIBIRCON.2017.8109939"},{"issue":"1","key":"492_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2008","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008;4(1):44.","journal-title":"Nat Protoc"},{"key":"492_CR32","first-page":"1","volume-title":"Exploring network structure, dynamics, and function using NetworkX","author":"A Hagberg","year":"2008","unstructured":"Hagberg A, Swart P, S Chult D. Exploring network structure, dynamics, and function using NetworkX. Los Alamos: Los Alamos National Lab.(LANL); 2008. p. 1\u20136."},{"issue":"3","key":"492_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1109\/MCSE.2007.58","volume":"9","author":"TE Oliphant","year":"2007","unstructured":"Oliphant TE. Python for scientific computing. Comput Sci Eng. 2007;9(3):9\u201312.","journal-title":"Comput Sci Eng"},{"issue":"2","key":"492_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/bioinformatics\/btn615","volume":"25","author":"S Carbon","year":"2008","unstructured":"Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S. AmiGO hub, web presence working group. AmiGO: online access to ontology and annotation data. Bioinformatics. 2008;25(2):288\u20139.","journal-title":"Bioinformatics"},{"issue":"7","key":"492_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","volume":"23","author":"AR Feinstein","year":"1970","unstructured":"Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455\u201368.","journal-title":"J Chronic Dis"},{"issue":"4","key":"492_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1134\/S1022795415040092","volume":"51","author":"VP Puzyrev","year":"2015","unstructured":"Puzyrev VP. Genetic bases of human comorbidity. Russ J Genet. 2015;51(4):408\u201317.","journal-title":"Russ J Genet"},{"issue":"1","key":"492_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.2044-8295.1906.tb00174.x","volume":"2","author":"C Spearman","year":"1906","unstructured":"Spearman C. \u2018Footrule\u2019for measuring correlation. Br J Psychol 1904\u20131920. 1906;2(1):89\u2013108.","journal-title":"Br J Psychol 1904\u20131920"},{"issue":"1","key":"492_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2045-5380-2-6","volume":"2","author":"J Radua","year":"2012","unstructured":"Radua J, Mataix-Cols D. Meta-analytic methods for neuroimaging data explained. Biology of mood & anxiety disorders. 2012;2(1):6.","journal-title":"Biology of mood & anxiety disorders"},{"issue":"7","key":"492_CR39","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1371\/journal.pmed.0030254","volume":"3","author":"R Tabibiazar","year":"2006","unstructured":"Tabibiazar R, Cheung L, Han J, Swanson J, Beilhack A, An A, et al. Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 2006;3(7):e254.","journal-title":"PLoS Med"},{"issue":"804675","key":"492_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/804675","volume":"2013","author":"Y Saito","year":"2013","unstructured":"Saito Y, Nakagami H, Kaneda Y, Morishita R. Lymphedema and therapeutic lymphangiogenesis. Biomed Res Int. 2013;2013(804675):1\u20136.","journal-title":"Biomed Res Int"},{"issue":"5","key":"492_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1172\/JCI15830","volume":"111","author":"YS Yoon","year":"2003","unstructured":"Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest. 2003;111(5):717\u201325.","journal-title":"J Clin Invest"},{"issue":"17","key":"492_CR42","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/j.yexcr.2011.07.023","volume":"317","author":"S Coso","year":"2011","unstructured":"Coso S, Zeng Y, Sooraj D, Williams ED. Conserved signaling through vascular endothelial growth (VEGF) receptor family members in murine lymphatic endothelial cells. Exp Cell Res. 2011;317(17):2397\u2013407.","journal-title":"Exp Cell Res"},{"issue":"5","key":"492_CR43","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","volume":"119","author":"J Kazenwadel","year":"2011","unstructured":"Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J, et al. Loss-of-function germline GATA2 mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2011;119(5):1283\u201391.","journal-title":"Blood"},{"issue":"1","key":"492_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1089\/lrb.2011.0024","volume":"10","author":"B Newman","year":"2012","unstructured":"Newman B, Lose F, Kedda MA, Francois M, Ferguson K, Janda M, et al. Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol. 2012;10(1):2\u201313.","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"492_CR45","first-page":"21","volume":"28","author":"TK Jenssen","year":"2001","unstructured":"Jenssen TK, L\u00e6greid A, Komorowski J, Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet. 2001;28(1):21.","journal-title":"Nat Genet"},{"issue":"1","key":"492_CR46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12885-017-3578-9","volume":"17","author":"Z Liu","year":"2017","unstructured":"Liu Z, Qi L, Li Y, Zhao X, Sun B. VEGFR2 regulates endothelial differentiation of colon cancer cells. BMC Cancer. 2017;17(1):593.","journal-title":"BMC Cancer"},{"issue":"1","key":"492_CR47","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.4081\/ejh.2014.2263","volume":"58","author":"JM Ou","year":"2014","unstructured":"Ou JM, Yu ZY, Qiu MK, Dai YX, Dong Q, Shen J, et al. Knockdown of VEGFR2 inhibits proliferation and induces apoptosis in hemangioma-derived endothelial cells. Eur J Histochem. 2014;58(1):2263.","journal-title":"Eur J Histochem"},{"issue":"2","key":"492_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12094-015-1358-z","volume":"18","author":"Y Liu","year":"2016","unstructured":"Liu Y, Qiao Y, Hu C, Liu L, Zhou L, Liu B, et al. VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells. Clin Transl Oncol. 2016;18(2):212\u20139.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"492_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","volume":"23","author":"K Gaengel","year":"2012","unstructured":"Gaengel K, Niaudet C, Hagikura K, Lavi\u00f1a B, Muhl L, Hofmann JJ, et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev Cell. 2012;23(3):587\u201399.","journal-title":"Dev Cell"},{"issue":"2","key":"492_CR50","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ydbio.2006.11.029","volume":"303","author":"M Tuyl van","year":"2007","unstructured":"van Tuyl M, Groenman F, Wang J, Kuliszewski M, Liu J, Tibboel D, et al. Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs. Dev Biol. 2007;303(2):514\u201326.","journal-title":"Dev Biol"},{"issue":"5","key":"492_CR51","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1096\/fj.08-123810","volume":"23","author":"S Mellberg","year":"2009","unstructured":"Mellberg S, Dimberg A, Bahram F, Hayashi M, Rennel E, Ameur A, et al. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J. 2009;23(5):1490\u2013502.","journal-title":"FASEB J"},{"issue":"2","key":"492_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10103-015-1854-y","volume":"31","author":"DH Jang","year":"2016","unstructured":"Jang DH, Song DH, Chang EJ, Jeon JY. Anti-inflammatory and lymphangiogenetic effects of low-level laser therapy on lymphedema in an experimental mouse tail model. Lasers Med Sci. 2016;31(2):289\u201396.","journal-title":"Lasers Med Sci"},{"issue":"6","key":"492_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/01.RES.88.6.623","volume":"88","author":"B Enholm","year":"2001","unstructured":"Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenbacz F, Prevo R, et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res. 2001;88(6):623\u20139.","journal-title":"Circ Res"},{"issue":"13","key":"492_CR54","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1096\/fj.99-1049com","volume":"14","author":"TA Partanen","year":"2000","unstructured":"Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000;14(13):2087\u201396.","journal-title":"FASEB J"},{"issue":"9","key":"492_CR55","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1046\/j.1432-1327.2000.01257.x","volume":"267","author":"MG Achen","year":"2000","unstructured":"Achen MG, Roufail S, Domagala T, Catimel B, Nice EC, Geleick DM, et al. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3. Eur J Biochem. 2000;267(9):2505\u201315.","journal-title":"Eur J Biochem"},{"issue":"12","key":"492_CR56","doi-asserted-by":"publisher","first-page":"e3848","DOI":"10.1371\/journal.pone.0003848","volume":"3","author":"RD Meyer","year":"2008","unstructured":"Meyer RD, Sacks DB, Rahimi N. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis. PLoS One. 2008;3(12):e3848.","journal-title":"PLoS One"},{"key":"492_CR57","doi-asserted-by":"crossref","unstructured":"Shin M, Male I, Beane TJ, Villefranc JA, Kok FO, Zhu LJ, Lawson ND. Vegfc acts through ERK to induce sprouting and differentiation of trunk lymphatic progenitors. Development. 2016;143(20):3785-3795.","DOI":"10.1242\/dev.137901"},{"key":"492_CR58","doi-asserted-by":"crossref","unstructured":"Le Guen L, Karpanen T, Schulte D, Harris NC, Koltowska K, Roukens G, Bower NI, Van Impel A, Stacker SA, Achen MG, Schulte-Merker S. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development. 2014;141(6):1239-49.","DOI":"10.1242\/dev.100495"},{"issue":"9","key":"492_CR59","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.jid.2017.04.033","volume":"137","author":"E Gousopoulos","year":"2017","unstructured":"Gousopoulos E, Proulx ST, Bachmann SB, Dieterich LC, Scholl J, Karaman S, et al. An important role of VEGF-C in promoting lymphedema development. J Investig Dermatol. 2017;137(9):1995\u20132004.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"492_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cge.13204","volume":"94","author":"E Fastr\u00e9","year":"2018","unstructured":"Fastr\u00e9 E, Lanteigne LE, Helaers R, Giacalone G, Revencu N, Dionyssiou D, et al. Splice-site mutations in VEGFC cause loss of function and nonne-Milroy-like primary lymphedema. Clin Genet. 2018;94(1):179\u201381.","journal-title":"Clin Genet"},{"issue":"6","key":"492_CR61","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1084\/jem.20020587","volume":"196","author":"A Saaristo","year":"2002","unstructured":"Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med. 2002;196(6):719\u201330.","journal-title":"J Exp Med"},{"issue":"2","key":"492_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1741-4520.2005.00064.x","volume":"45","author":"S Mizuno","year":"2005","unstructured":"Mizuno S, Yamada Y, Yamada K, Nomura N, Wakamatsu N. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation. Congenit Anom. 2005;45(2):59\u201361.","journal-title":"Congenit Anom"},{"issue":"4","key":"492_CR63","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ajmg.a.36375","volume":"164","author":"HL Hanson","year":"2014","unstructured":"Hanson HL, Wilson MJ, Short JP, Chioza BA, Crosby AH, Nash RM, et al. Germline CBL mutation associated with a Noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23. Am J Med Genet A. 2014;164(4):1003\u20139.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"492_CR64","first-page":"185","volume":"37","author":"AM Fink","year":"2004","unstructured":"Fink AM, Kaltenegger I, Schneider B, Fruhauf J, Jurecka W, Steiner A. Serum level of VEGF-D in patients with primary lymphedema. Lymphology. 2004;37(4):185\u20139.","journal-title":"Lymphology"},{"issue":"5","key":"492_CR65","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/PAI.0b013e31827da3f9","volume":"21","author":"C Tang","year":"2013","unstructured":"Tang C, Luo D, Yang H, Wang Q, Zhang R, Liu G, et al. Expression of SHP2 and related markers in non\u2013small cell lung cancer: a tissue microarray study of 80 cases. Appl Immunohistochem Mol Morphol. 2013;21(5):386\u201394.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"492_CR66","doi-asserted-by":"publisher","first-page":"e34901","DOI":"10.1371\/journal.pone.0034901","volume":"7","author":"CH Yeang","year":"2012","unstructured":"Yeang CH, Ma GC, Shih JC, Yang YS, Chen CP, Chang SP, et al. Genome-wide gene expression analysis implicates the immune response and lymphangiogenesis in the pathogenesis of fetal chylothorax. PLoS One. 2012;7(4):e34901.","journal-title":"PLoS One"},{"issue":"9","key":"492_CR67","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BC20080221","volume":"101","author":"E Sulpice","year":"2009","unstructured":"Sulpice E, Ding S, Muscatelli-Groux B, Berg\u00e9 M, Han ZC, Plouet J, et al. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol Cell. 2009;101(9):525\u201339.","journal-title":"Biol Cell"},{"issue":"2","key":"492_CR68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/lrb.2008.1524","volume":"6","author":"DN Finegold","year":"2008","unstructured":"Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, et al. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol. 2008;6(2):65\u20138.","journal-title":"Lymphat Res Biol"},{"issue":"2","key":"492_CR69","first-page":"57","volume":"49","author":"S Michelini","year":"2016","unstructured":"Michelini S, Vettori A, Maltese PE, Cardone M, Bruson A, Fiorentino A, et al. Genetic screening in a large cohort of italian patients affected by primary lymphedema using a next generation sequencing (NGS) approach. Lymphology. 2016;49(2):57\u201372.","journal-title":"Lymphology"},{"issue":"11","key":"492_CR70","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1161\/CIRCULATIONAHA.105.602953","volume":"114","author":"Y Saito","year":"2006","unstructured":"Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation. 2006;114(11):1177\u201384.","journal-title":"Circulation"},{"issue":"1","key":"492_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13287-016-0296-1","volume":"7","author":"CY Lee","year":"2016","unstructured":"Lee CY, Kang JY, Lim S, Ham O, Chang W, Jang DH. Hypoxic conditioned medium from mesenchymal stem cells promotes lymphangiogenesis by regulation of mitochondrial-related proteins. Stem Cell Res Ther. 2016;7(1):38.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"492_CR72","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","volume":"48","author":"C Popa","year":"2007","unstructured":"Popa C, Netea MG, Van Riel PL, Van Der Meer JW, Stalenhoef AF. The role of TNF-\u03b1 in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res. 2007;48(4):751\u201362.","journal-title":"J Lipid Res"},{"issue":"3","key":"492_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000052610","volume":"9","author":"N Tomita","year":"2001","unstructured":"Tomita N, Morishita R, Tomita S, Kaneda Y, Higaki J, Ogihara T, et al. Inhibition of TNF-\u03b1, induced cytokine and adhesion molecule. Nephron Exp Nephrol. 2001;9(3):181\u201390.","journal-title":"Nephron Exp Nephrol"},{"issue":"2","key":"492_CR74","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4049\/jimmunol.168.2.861","volume":"168","author":"M Shimada","year":"2002","unstructured":"Shimada M, Andoh A, Hata K, Tasaki K, Araki Y, Fujiyama Y, et al. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol. 2002;168(2):861\u20138.","journal-title":"J Immunol"},{"key":"492_CR75","first-page":"580135","volume":"2013","author":"C Lee","year":"2013","unstructured":"Lee C, Oh JI, Park J, Choi JH, Bae EK, Lee HJ, et al. TNF\u03b1 mediated IL-6 secretion is regulated by JAK\/STAT pathway but not by MEK phosphorylation and AKT phosphorylation in U266 multiple myeloma cells. Biomed Res Int. 2013;2013:580135.","journal-title":"Biomed Res Int"},{"issue":"10","key":"492_CR76","first-page":"H1426","volume":"306","author":"DA Cuzzone","year":"2014","unstructured":"Cuzzone DA, Weitman ES, Albano NJ, Ghanta S, Savetsky IL, Gardenier JC, et al. IL-6 regulates adipose deposition and homeostasis in lymphedema. Am J Phys Heart Circ Phys. 2014;306(10):H1426\u201334.","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"10","key":"492_CR77","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0961203307081895","volume":"16","author":"V Barkauskaite","year":"2007","unstructured":"Barkauskaite V, Ek M, Popovic K, Harris HE, Wahren-Herlenius M, Nyberg F. Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus. 2007;16(10):794\u2013802.","journal-title":"Lupus"},{"issue":"5","key":"492_CR78","doi-asserted-by":"publisher","first-page":"C1107","DOI":"10.1152\/ajpcell.00378.2010","volume":"300","author":"JC Zampell","year":"2011","unstructured":"Zampell JC, Yan A, Avraham T, Andrade V, Malliaris S, Aschen S, et al. Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema. Am J Phys Cell Phys. 2011;300(5):C1107\u201321.","journal-title":"Am J Phys Cell Phys"},{"issue":"4","key":"492_CR79","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00424-006-0055-8","volume":"452","author":"B Wang","year":"2006","unstructured":"Wang B, Trayhurn P. Acute and prolonged effects of TNF-\u03b1 on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch. 2006;452(4):418\u201327.","journal-title":"Pflugers Arch"},{"issue":"5","key":"492_CR80","doi-asserted-by":"publisher","first-page":"e000438","DOI":"10.1161\/JAHA.113.000438","volume":"2","author":"Y Shimizu","year":"2013","unstructured":"Shimizu Y, Shibata R, Ishii M, Ohashi K, Kambara T, Uemura Y, et al. Adiponectin-mediated modulation of lymphatic vessel formation and lymphedema. J Am Heart Assoc. 2013;2(5):e000438.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"492_CR81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1043-4666(03)00150-9","volume":"22","author":"E Mari\u00f1o","year":"2003","unstructured":"Mari\u00f1o E, Cardier JE. Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-\u03b1 and Fas (CD95). Cytokine. 2003;22(5):142\u20138.","journal-title":"Cytokine."},{"issue":"8","key":"492_CR82","first-page":"10090","volume":"93","author":"FJ Lejeune","year":"2006","unstructured":"Lejeune FJ, R\u00fcegg C. Recombinant human tumor necrosis factor: an efficient agent for cancer treatment. Bull Cancer. 2006;93(8):10090\u2013100.","journal-title":"Bull Cancer"},{"issue":"1","key":"492_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cyto.2009.09.011","volume":"49","author":"N Acquavella","year":"2010","unstructured":"Acquavella N, Quiroga MF, Wittig O, Cardier JE. Effect of simvastatin on endothelial cell apoptosis mediated by Fas and TNF-\u03b1. Cytokine. 2010;49(1):45\u201350.","journal-title":"Cytokine."},{"issue":"1","key":"492_CR84","first-page":"19","volume":"33","author":"E Foldi","year":"2000","unstructured":"Foldi E, Sauerwald A, Hennig B. Effect of complex decongestive physiotherapy on gene expression for the inflammatory response in peripheral lymphedema. Lymphology. 2000;33(1):19\u201323.","journal-title":"Lymphology."},{"issue":"22","key":"492_CR85","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2174\/092986707781745541","volume":"14","author":"RC Ji","year":"2007","unstructured":"Ji RC. Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players. Curr Med Chem. 2007;14(22):2359\u201368.","journal-title":"Curr Med Chem"},{"issue":"6","key":"492_CR86","doi-asserted-by":"publisher","first-page":"e1002749","DOI":"10.1371\/journal.ppat.1002749","volume":"8","author":"R Anuradha","year":"2012","unstructured":"Anuradha R, George PJ, Kumar NP, Fay MP, Kumaraswami V, Nutman TB, et al. Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease. PLoS Pathog. 2012;8(6):e1002749.","journal-title":"PLoS Pathog"},{"issue":"4","key":"492_CR87","first-page":"160","volume":"46","author":"HJ Jeong","year":"2013","unstructured":"Jeong HJ, Roh K, Kim G, Kim Y, Lee J, Lee M, et al. Hyaluronidase treatment of acute lymphedema in a mouse tail model. Lymphology. 2013;46(4):160\u201372.","journal-title":"Lymphology."},{"issue":"16","key":"492_CR88","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1101\/gad.8.16.1897","volume":"8","author":"DJ Dumont","year":"1994","unstructured":"Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 1994;8(16):1897\u2013909.","journal-title":"Genes Dev"},{"issue":"9","key":"492_CR89","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/jid.2008.89","volume":"128","author":"HT Hu","year":"2008","unstructured":"Hu HT, Huang YH, Chang YA, Lee CK, Jiang MJ, Wu LW. Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. J Investig Dermatol. 2008;128(9):2325\u201333.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"492_CR90","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MOO.0b013e3283587415","volume":"20","author":"A Frigerio","year":"2012","unstructured":"Frigerio A, Stevenson DA, Grimmer JF. The genetics of vascular anomalies. Curr Opin Otolaryngol Head Neck Surg. 2012;20(6):527\u201332.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"5\u20136","key":"492_CR91","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/08820538.2013.825279","volume":"28","author":"P Yadav","year":"2013","unstructured":"Yadav P, De Castro DK, Waner M, Meyer L, Fay A. Vascular anomalies of the head and neck: a review of genetics. Semin Ophthalmol. 2013;28(5\u20136):257\u201366.","journal-title":"Semin Ophthalmol"},{"issue":"10","key":"492_CR92","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1172\/JCI77162","volume":"124","author":"BR Thomson","year":"2014","unstructured":"Thomson BR, Heinen S, Jeansson M, Ghosh AK, Fatima A, Sung HK, et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J Clin Invest. 2014;124(10):4320\u20134.","journal-title":"J Clin Invest"},{"issue":"34","key":"492_CR93","doi-asserted-by":"publisher","first-page":"54228","DOI":"10.18632\/oncotarget.9797","volume":"7","author":"D Tavian","year":"2016","unstructured":"Tavian D, Missaglia S, Maltese PE, Michelini S, Fiorentino A, Ricci M, et al. FOXC2 disease-mutations identified in lymphedema-distichiasis patients cause both loss and gain of protein function. Oncotarget. 2016;7(34):54228.","journal-title":"Oncotarget"},{"issue":"D1","key":"492_CR94","doi-asserted-by":"publisher","first-page":"D1228","DOI":"10.1093\/nar\/gks1147","volume":"41","author":"K Breuer","year":"2012","unstructured":"Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, Lo R, et al. InnateDB: systems biology of innate immunity and beyond\u2014recent updates and continuing curation. Nucleic Acids Res. 2012;41(D1):D1228\u201333.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"492_CR95","first-page":"D767","volume":"37","author":"TS Keshava Prasad","year":"2008","unstructured":"Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L. Human protein reference database\u20142009 update. Nucleic Acids Res. 2008;37(suppl_1):D767\u201372.","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"492_CR96","doi-asserted-by":"publisher","first-page":"D535","DOI":"10.1093\/nar\/gkj109","volume":"34","author":"C Stark","year":"2006","unstructured":"Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 2006;34(suppl_1):D535\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"492_CR97","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00431-010-1206-7","volume":"169","author":"CM Roberts","year":"2010","unstructured":"Roberts CM, Angus JE, Leach IH, McDermott EM, Walker DA, Ravenscroft JC. A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID). Eur J Pediatr. 2010;169(11):1403\u20137.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"492_CR98","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.bbrc.2007.08.045","volume":"362","author":"YT Xiao","year":"2007","unstructured":"Xiao YT, Xiang LX, Shao JZ. Bone morphogenetic protein. Biochem Biophys Res Commun. 2007;362(3):550\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"492_CR99","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1172\/JCI65592","volume":"123","author":"E Spiekerkoetter","year":"2013","unstructured":"Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, et al. FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest. 2013;123(8):3600\u201313.","journal-title":"J Clin Invest"},{"issue":"4","key":"492_CR100","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cmet.2015.03.010","volume":"21","author":"I Diebold","year":"2015","unstructured":"Diebold I, Hennigs JK, Miyagawa K, Li CG, Nickel NP, Kaschwich M, et al. BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension. Cell Metab. 2015;21(4):596\u2013608.","journal-title":"Cell Metab"},{"issue":"3","key":"492_CR101","doi-asserted-by":"publisher","first-page":"270","DOI":"10.14348\/molcells.2014.0005","volume":"37","author":"JD Kim","year":"2014","unstructured":"Kim JD, Kim J. Alk3\/Alk3b and Smad5 mediate BMP signaling during lymphatic development in zebrafish. Mol Cells. 2014;37(3):270.","journal-title":"Mol Cells"},{"issue":"1","key":"492_CR102","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1475-2867-14-55","volume":"14","author":"P Zeng","year":"2014","unstructured":"Zeng P, Cai S, Zhang JN, Yi FM, Jiang WM, Wu JB. Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism. Cancer Cell Int. 2014;14(1):55.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"492_CR103","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1164\/rccm.201408-1509OC","volume":"192","author":"E Soon","year":"2015","unstructured":"Soon E, Crosby A, Southwood M, Yang P, Tajsic T, Toshner M, et al. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2015;192(7):859\u201372.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"492_CR104","first-page":"521","volume":"30","author":"L Ye","year":"2007","unstructured":"Ye L, Lewis-Russell JM, Davies G, Sanders AJ, Kynaston H, Jiang WG. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells. Int J Oncol. 2007;30(2):521\u20139.","journal-title":"Int J Oncol"},{"issue":"3","key":"492_CR105","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jvs.2007.01.005","volume":"45","author":"Y Saito","year":"2007","unstructured":"Saito Y, Nakagami H, Morishita R. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. J Vasc Surg. 2007;45(3):637.","journal-title":"J Vasc Surg"},{"issue":"4","key":"492_CR106","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/ajmg.a.35229","volume":"158","author":"MG Butler","year":"2012","unstructured":"Butler MG, Dagenais SL, Garcia-Perez JL, Brouillard P, Vikkula M, Strouse P, et al. Microcephaly, intellectual impairment, bilateral vesicoureteral reflux, distichiasis, and glomuvenous malformations associated with a 16q24. 3 contiguous gene deletion and a Glomulin mutation. Am J Med Genet A. 2012;158(4):839\u201349.","journal-title":"Am J Med Genet A"},{"issue":"8","key":"492_CR107","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/ijms18081651","volume":"18","author":"Y Ye","year":"2017","unstructured":"Ye Y, Vattai A, Zhang X, Zhu J, Thaler CJ, Mahner S, et al. Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases. Int J Mol Sci. 2017;18(8):1651.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"492_CR108","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11011-017-0007-3","volume":"32","author":"R Chen","year":"2017","unstructured":"Chen R, Yan J, Liu P, Wang Z, Wang C. Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: the roles of PAI-1 and obesity on stroke. Metab Brain Dis. 2017;32(3):667\u201373.","journal-title":"Metab Brain Dis"},{"issue":"9","key":"492_CR109","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1111\/jcmm.13127","volume":"21","author":"H Yao","year":"2017","unstructured":"Yao H, He G, Chen C, Yan S, Lu L, Song L, et al. PAI1: a novel PP1-interacting protein that mediates human plasma's anti-apoptotic effect in endothelial cells. J Cell Mol Med. 2017;21(9):2068\u201376.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"492_CR110","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.prp.2011.02.008","volume":"207","author":"D Eljuga","year":"2011","unstructured":"Eljuga D, Razumovic JJ, Bulic K, Petrovecki M, Draca N, Bulic SO. Prognostic importance of PAI-1 in node negative breast cancer patients\u2014results after 10 years of follow up. Pathol Res Pract. 2011;207(5):290\u20134.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"492_CR111","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/bjc.2014.500","volume":"111","author":"J Dhanda","year":"2014","unstructured":"Dhanda J, Triantafyllou A, Liloglou T, Kalirai H, Lloyd B, Hanlon R, et al. SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma. Br J Cancer. 2014;111(11):2114.","journal-title":"Br J Cancer"},{"issue":"18","key":"492_CR112","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.3748\/wjg.v20.i18.5533","volume":"20","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zhang YL, Chen HM, Pu HW, Ma WJ, Li XM, et al. Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma. World J Gastroenterol: WJG. 2014;20(18):5533.","journal-title":"World J Gastroenterol: WJG"},{"issue":"30","key":"492_CR113","doi-asserted-by":"publisher","first-page":"29240","DOI":"10.18632\/oncotarget.5074","volume":"6","author":"Y Sang","year":"2015","unstructured":"Sang Y, Chen MY, Luo D, Zhang RH, Wang L, Li M, et al. TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma. Oncotarget. 2015;6(30):29240.","journal-title":"Oncotarget"},{"issue":"1","key":"492_CR114","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1447-0756.2012.01898.x","volume":"39","author":"K Umemura","year":"2013","unstructured":"Umemura K, Ishioka SI, Endo T, Ezaka Y, Takahashi M, Saito T. Roles of microRNA-34a in the pathogenesis of placenta accreta. J Obstet Gynaecol Res. 2013;39(1):67\u201374.","journal-title":"J Obstet Gynaecol Res"},{"issue":"10","key":"492_CR115","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1161\/01.ATV.0000240318.61359.e3","volume":"26","author":"S Imagawa","year":"2006","unstructured":"Imagawa S, Fujii S, Dong J, Furumoto T, Kaneko T, Zaman T, et al. Hepatocyte growth factor regulates E box\u2013dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells. Arterioscler Thromb Vasc Biol. 2006;26(10):2407\u201313.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"492_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JBM.S93008","volume":"7","author":"S Nomura","year":"2016","unstructured":"Nomura S, Maeda Y, Ishii K, Katayama Y, Yagi H, Fujishima N, et al. Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation. J Blood Med. 2016;7:1\u20134.","journal-title":"J Blood Med"},{"key":"492_CR117","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2147\/IJGM.S31346","volume":"5","author":"S Nomura","year":"2012","unstructured":"Nomura S, Taniura T, Shouzu A, Omoto S, Inami N, Fujita S, et al. Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients. Int J General Med. 2012;5:535.","journal-title":"Int J General Med"},{"issue":"1\u20133","key":"492_CR118","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","volume":"47","author":"CM Hedrich","year":"2010","unstructured":"Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res. 2010;47(1\u20133):185\u2013206.","journal-title":"Immunol Res"},{"issue":"4\u20135","key":"492_CR119","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejcb.2013.01.001","volume":"92","author":"Y Yin","year":"2013","unstructured":"Yin Y, Liu W, Ji G, Dai Y. The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis. Eur J Cell Biol. 2013;92(4\u20135):150\u20139.","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"492_CR120","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2567.2001.01171.x","volume":"102","author":"ZQ Wang","year":"2001","unstructured":"Wang ZQ, Bapat AS, Rayanade RJ, Dagtas AS, Hoffmann MK. Interleukin-10 induces macrophage apoptosis and expression of CD16 (Fc\u03b3RIII) whose engagement blocks the cell death programme and facilitates differentiation. Immunology. 2001;102(3):331\u20137.","journal-title":"Immunology"},{"issue":"5","key":"492_CR121","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.clindermatol.2014.04.006","volume":"32","author":"A Baroni","year":"2014","unstructured":"Baroni A, Buommino E, Piccolo V, Chessa MA, Russo T, Cozza V, et al. Alterations of skin innate immunity in lymphedematous limbs: correlations with opportunistic diseases. Clin Dermatol. 2014;32(5):592\u20138.","journal-title":"Clin Dermatol"},{"issue":"1","key":"492_CR122","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1189\/jlb.0812408","volume":"94","author":"T Kimura","year":"2013","unstructured":"Kimura T, Sugaya M, Blauvelt A, Okochi H, Sato S. Delayed wound healing due to increased interleukin-10 expression in mice with lymphatic dysfunction. J Leukoc Biol. 2013;94(1):137\u201345.","journal-title":"J Leukoc Biol"},{"issue":"17","key":"492_CR123","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1161\/01.CIR.0000127953.98131.ED","volume":"109","author":"M Kumada","year":"2004","unstructured":"Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation. 2004;109(17):2046\u20139.","journal-title":"Circulation"},{"issue":"1","key":"492_CR124","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2003.12.015","volume":"486","author":"Z Warzecha","year":"2004","unstructured":"Warzecha Z, Dembi\u0144ski A, Ceranowicz P, Konturek SJ, Tomaszewska R, Stachura J, et al. Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis. Eur J Pharmacol. 2004;486(1):107\u201319.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"492_CR125","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1189\/jlb.3A0513-242R","volume":"96","author":"PM Chen","year":"2014","unstructured":"Chen PM, Liu KJ, Hsu PJ, Wei CF, Bai CH, Ho LJ, et al. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1\/2. J Leukoc Biol. 2014;96(2):295\u2013303.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"492_CR126","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20031705","volume":"199","author":"SA Mikolajczak","year":"2004","unstructured":"Mikolajczak SA, Ma BY, Yoshida T, Yoshida R, Kelvin DJ, Ochi A. The modulation of CD40 ligand signaling by transmembrane CD28 splice variant in human T cells. J Exp Med. 2004;199(7):1025\u201331.","journal-title":"J Exp Med"},{"issue":"9","key":"492_CR127","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.4049\/jimmunol.156.9.3133","volume":"156","author":"MH Blotta","year":"1996","unstructured":"Blotta MH, Marshall JD, DeKruyff RH, Umetsu DT. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J Immunol. 1996;156(9):3133\u201340.","journal-title":"J Immunol"},{"issue":"1","key":"492_CR128","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1477-7827-10-28","volume":"10","author":"CF Wu","year":"2012","unstructured":"Wu CF, Huang FD, Sui RF, Sun JX. Preeclampsia serum upregulates CD40\/CD40L expression and induces apoptosis in human umbilical cord endothelial cells. Reprod Biol Endocrinol. 2012;10(1):28.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1\u20133","key":"492_CR129","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.vetimm.2008.10.294","volume":"128","author":"S Sommer","year":"2009","unstructured":"Sommer S, Pudrith CB, Colvin CJ, Coussens PM. Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages. Vet Immunol Immunopathol. 2009;128(1\u20133):44\u201352.","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"492_CR130","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1182\/blood-2002-09-2773","volume":"102","author":"P Ogilvie","year":"2003","unstructured":"Ogilvie P, Paoletti S, Clark-Lewis I, Uguccioni M. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood. 2003;102(3):789\u201394.","journal-title":"Blood."},{"issue":"2","key":"492_CR131","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.175.2.489","volume":"175","author":"P Kuna","year":"1992","unstructured":"Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992;175(2):489\u201393.","journal-title":"J Exp Med"},{"issue":"1","key":"492_CR132","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.thromres.2014.10.027","volume":"135","author":"D Liu","year":"2015","unstructured":"Liu D, Zhang XL, Yan CH, Li Y, Tian XX, Zhu N, et al. MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2. Thromb Res. 2015;135(1):146\u201354.","journal-title":"Thromb Res"},{"issue":"4","key":"492_CR133","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ajmg.a.37526","volume":"170","author":"T Takenouchi","year":"2016","unstructured":"Takenouchi T, Okamoto N, Ida S, Uehara T, Kosaki K. Further evidence of a mutation in CDC42 as a cause of a recognizable syndromic form of thrombocytopenia. Am J Med Genet A. 2016;170(4):852\u20135.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"492_CR134","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaad.2012.03.021","volume":"67","author":"D Kacerovska","year":"2012","unstructured":"Kacerovska D, Kerl K, Michal M, Filipova H, Vrtel R, Vanecek T, et al. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis. J Am Acad Dermatol. 2012;67(6):1319\u201326.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"492_CR135","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1097\/BPO.0000000000000240","volume":"34","author":"P Navarre","year":"2014","unstructured":"Navarre P, Poitras B. Lymphoedema in tuberous sclerosis: case report and review of the literature. J Pediatr Orthop. 2014;34(6):e27\u201332.","journal-title":"J Pediatr Orthop"},{"issue":"3","key":"492_CR136","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cyto.2011.08.017","volume":"56","author":"M Neumeier","year":"2011","unstructured":"Neumeier M, Bauer S, Br\u00fchl H, Eisinger K, Kopp A, Abke S, et al. Adiponectin stimulates release of CCL2, \u22123, \u22124 and \u22125 while the surface abundance of CCR2 and \u22125 is simultaneously reduced in primary human monocytes. Cytokine. 2011;56(3):573\u201380.","journal-title":"Cytokine."},{"issue":"6","key":"492_CR137","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1242\/jcs.01707","volume":"118","author":"CF Deroanne","year":"2005","unstructured":"Deroanne CF, Hamelryckx D, Ho TG, Lambert CA, Catroux P, Lapi\u00e8re CM, et al. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1\/2 pathway. J Cell Sci. 2005;118(6):1173\u201383.","journal-title":"J Cell Sci"},{"issue":"1\u20132","key":"492_CR138","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2012.06.008","volume":"251","author":"AM M\u00fcller","year":"2012","unstructured":"M\u00fcller AM, Jun E, Conlon H, Sadiq SA. Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis. J Neuroimmunol. 2012;251(1\u20132):80\u20136.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"492_CR139","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12885-015-1500-x","volume":"15","author":"M Thomas","year":"2015","unstructured":"Thomas M, Bayha C, Klein K, M\u00fcller S, Weiss TS, Schwab M, et al. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPAR\u03b1-tr, autonomously regulates proliferative and pro-inflammatory genes. BMC Cancer. 2015;15(1):488.","journal-title":"BMC Cancer"},{"key":"492_CR140","first-page":"830","volume":"18","author":"CM Cheung","year":"2012","unstructured":"Cheung CM, Vania M, Ang M, Chee SP, Li J. Comparison of aqueous humor cytokine and chemokine levels in diabetic patients with and without retinopathy. Mol Vis. 2012;18:830.","journal-title":"Mol Vis"},{"issue":"5","key":"492_CR141","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1084\/jem.20042469","volume":"202","author":"S Li","year":"2005","unstructured":"Li S, Takeuchi F, Wang JA, Fuller C, Pacheco-Rodriguez G, Moss J, et al. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J Exp Med. 2005;202(5):617\u201324.","journal-title":"J Exp Med"},{"key":"492_CR142","doi-asserted-by":"crossref","unstructured":"Ruiz-Garc\u00eda R, Mora S, Lozano-S\u00e1nchez G, Mart\u00ednez-Lostao L, Paz-Artal E, Ruiz-Contreras J, Anel A, Gonz\u00e1lez-Granado LI, Moreno D, Allende LM. Decreased activation-induced cell death by EBV-transformed B cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation. Pediatr Res. 2015;78(6):603-8.","DOI":"10.1038\/pr.2015.170"},{"issue":"30","key":"492_CR143","doi-asserted-by":"publisher","first-page":"18827","DOI":"10.1074\/jbc.272.30.18827","volume":"272","author":"P Schneider","year":"1997","unstructured":"Schneider P, Bodmer JL, Holler N, Mattmann C, Scuderi P, Terskikh A, et al. Characterization of Fas (Apo-1, CD95)-fas ligand interaction. J Biol Chem. 1997;272(30):18827\u201333.","journal-title":"J Biol Chem"},{"issue":"5","key":"492_CR144","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/002215540405200513","volume":"52","author":"TS Kokkonen","year":"2004","unstructured":"Kokkonen TS, Augustin MT, M\u00e4kinen JM, Kokkonen J, Karttunen TJ. High endothelial venules of the lymph nodes express Fas ligand. J Histochem Cytochem. 2004;52(5):693\u20139.","journal-title":"J Histochem Cytochem"},{"issue":"12","key":"492_CR145","doi-asserted-by":"publisher","first-page":"e80555","DOI":"10.1371\/journal.pone.0080555","volume":"8","author":"RK Verma","year":"2013","unstructured":"Verma RK, Gunda V, Pawar SC, Sudhakar YA. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis. PLoS One. 2013;8(12):e80555.","journal-title":"PLoS One"},{"issue":"3","key":"492_CR146","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bcp.2014.09.012","volume":"92","author":"Q Gong","year":"2014","unstructured":"Gong Q, Qiu S, Li S, Ma Y, Chen M, Yao Y, et al. Proapoptotic PEDF functional peptides inhibit prostate tumor growth\u2014a mechanistic study. Biochem Pharmacol. 2014;92(3):425\u201337.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"492_CR147","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3109\/02841860902988688","volume":"48","author":"J Sj\u00f6str\u00f6m-Mattson","year":"2009","unstructured":"Sj\u00f6str\u00f6m-Mattson J, Von Boguslawski K, Bengtsson NO, Mjaaland I, Salmenkivi K, Blomqvist C. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Acta Oncol. 2009;48(8):1137\u201343.","journal-title":"Acta Oncol"},{"issue":"10","key":"492_CR148","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3748\/wjg.v16.i10.1274","volume":"16","author":"Q Li","year":"2010","unstructured":"Li Q, Peng J, Li XH, Liu T, Liang QC, Zhang GY. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues. World J Gastroenterol: WJG. 2010;16(10):1274.","journal-title":"World J Gastroenterol: WJG"},{"issue":"12","key":"492_CR149","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00432-010-0839-2","volume":"136","author":"G Knechtel","year":"2010","unstructured":"Knechtel G, Hofmann G, Gerger A, Renner W, Langsenlehner T, Szkandera J, et al. Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol. 2010;136(12):1813\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"492_CR150","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/SHK.0b013e318213665d","volume":"35","author":"DH Seitz","year":"2011","unstructured":"Seitz DH, Palmer A, Niesler U, Braum\u00fcller ST, Bauknecht S, Gebhard F, et al. Altered expression of Fas receptor on alveolar macrophages and inflammatory effects of soluble Fas ligand following blunt chest trauma. Shock. 2011;35(6):610\u20137.","journal-title":"Shock."},{"issue":"1","key":"492_CR151","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41598-017-00800-w","volume":"7","author":"M Cobbaut","year":"2017","unstructured":"Cobbaut M, Derua R, D\u00f6ppler H, Lou HJ, Vandoninck S, Storz P, et al. Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+ 1 loop. Sci Rep. 2017;7(1):887.","journal-title":"Sci Rep"},{"key":"492_CR152","doi-asserted-by":"crossref","unstructured":"Xu J, Millard M, Ren X, Cox OT, Erdreich-Epstein A. c-Abl mediates endothelial apoptosis induced by inhibition of integrins \u03b1v\u03b23 and \u03b1v\u03b25 and by disruption of actin. Blood. 2010;115(13):2709-18.","DOI":"10.1182\/blood-2009-05-223776"},{"issue":"26","key":"492_CR153","doi-asserted-by":"publisher","first-page":"21799","DOI":"10.18632\/oncotarget.4848","volume":"6","author":"J Liebl","year":"2015","unstructured":"Liebl J. Cdk5 and Foxc2\u2013a new relationship in the lymphatic vasculature. Oncotarget. 2015;6(26):21799.","journal-title":"Oncotarget."},{"key":"492_CR154","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.breast.2016.06.023","volume":"29","author":"MR Fu","year":"2016","unstructured":"Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, et al. Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast. 2016;29:231\u201340.","journal-title":"Breast"},{"issue":"11","key":"492_CR155","doi-asserted-by":"publisher","first-page":"e112548","DOI":"10.1371\/journal.pone.0112548","volume":"9","author":"GD Agollah","year":"2014","unstructured":"Agollah GD, Gonzalez-Garay ML, Rasmussen JC, Tan IC, Aldrich MB, Darne C, et al. Evidence for SH2 domain-containing 5\u2032-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunction. PLoS One. 2014;9(11):e112548.","journal-title":"PLoS One"},{"issue":"12","key":"492_CR156","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/ajmg.a.35639","volume":"158","author":"P Smpokou","year":"2012","unstructured":"Smpokou P, Tworog-Dube E, Kucherlapati RS, Roberts AE. Medical complications, clinical findings, and educational outcomes in adults with Noonan syndrome. Am J Med Genet A. 2012;158(12):3106\u201311.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"492_CR157","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/humu.22834","volume":"36","author":"V Cordeddu","year":"2015","unstructured":"Cordeddu V, Yin JC, Gunnarsson C, Virtanen C, Drunat S, Lepri F, et al. Activating mutations affecting the Dbl homology domain of SOS2 cause Noonan syndrome. Hum Mutat. 2015;36(11):1080\u20137.","journal-title":"Hum Mutat"},{"issue":"5","key":"492_CR158","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","volume":"20","author":"D Reynaud","year":"2011","unstructured":"Reynaud D, Pietras E, Barry-Holson K, Mir A, Binnewies M, Jeanne M, et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell. 2011;20(5):661\u201373.","journal-title":"Cancer Cell"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-019-0492-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T13:50:52Z","timestamp":1694699452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-019-0492-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":158,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1186\/s12920-019-0492-9","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"13 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"47"}}